ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,121.01
-0.35%
Dow Jones
42,678.05
-0.73%
Gold vs US Dollar
2,602.925
-0.81%
Brent Oil
74.36
1.00%
Bitcoin
93,474.46
-0.05%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immuneering Corporation (IMRX)

  7. Immuneering Corporation (IMRX) News

Immuneering (IMRX)

Immuneering Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMRX
DateTimeSourceHeadlineSymbolCompany
19/12/202413:00GlobeNewswire Inc.Immuneering Launches Pancreatic Cancer Advisory BoardNASDAQ:IMRXImmuneering Corporation
17/12/202413:00GlobeNewswire Inc.Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025NASDAQ:IMRXImmuneering Corporation
12/12/202413:00GlobeNewswire Inc.Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced MelanomaNASDAQ:IMRXImmuneering Corporation
27/11/202413:00GlobeNewswire Inc.Immuneering to Present at the Piper Sandler 36ᵗʰ Annual Healthcare ConferenceNASDAQ:IMRXImmuneering Corporation
13/11/202421:05GlobeNewswire Inc.Immuneering Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IMRXImmuneering Corporation
13/11/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
15/10/202417:00AllPennyStocks.comBiotech Shares Rip Following FDA Designation AnnouncementNASDAQ:IMRXImmuneering Corporation
15/10/202412:00GlobeNewswire Inc.Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic CancerNASDAQ:IMRXImmuneering Corporation
02/10/202420:11Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:IMRXImmuneering Corporation
17/09/202420:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
13/09/202413:40AllPennyStocks.comBiotech Surges Premarket Following Positive Phase 2a ObservationsNASDAQ:IMRXImmuneering Corporation
12/09/202420:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
12/09/202420:05GlobeNewswire Inc.Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer PatientsNASDAQ:IMRXImmuneering Corporation
29/08/202412:00GlobeNewswire Inc.Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:IMRXImmuneering Corporation
06/08/202420:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMRXImmuneering Corporation
06/08/202420:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
06/08/202420:05GlobeNewswire Inc.Immuneering Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IMRXImmuneering Corporation
31/07/202420:05GlobeNewswire Inc.Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic CancerNASDAQ:IMRXImmuneering Corporation
13/06/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
13/06/202420:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
29/05/202420:05GlobeNewswire Inc.Immuneering to Present at the Jefferies Global Healthcare ConferenceNASDAQ:IMRXImmuneering Corporation
23/05/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
23/05/202420:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
23/05/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
23/05/202420:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
23/05/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
07/05/202420:05GlobeNewswire Inc.Immuneering Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IMRXImmuneering Corporation
07/05/202420:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
06/05/202420:30GlobeNewswire Inc.Immuneering Recognizes Melanoma Awareness MonthNASDAQ:IMRXImmuneering Corporation
09/04/202416:00GlobeNewswire Inc.IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer ModelsNASDAQ:IMRXImmuneering Corporation
 Showing the most relevant articles for your search:NASDAQ:IMRX

Your Recent History

BIT
NSCIT45905C6
World Bank
BIT
NSCIT1218808
International Bank for R...
NASDAQ
LPTH
Lightpath Technologies
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads